What We're Watching: December 4, 2018

A panel of industry experts met last week to discuss the root causes of drug shortages and solutions to the problem during a day-long meeting hosted by the FDA. Panel participants, including Premier, widely suggested that the lack of competition is a major barrier to improvement, and transparency and improved payment is needed.<br />What we’re saying:...

A panel of industry experts met last week to discuss the root causes of drug shortages and solutions to the problem during a day-long meeting hosted by the FDA. Panel participants, including Premier, widely suggested that the lack of competition is a major barrier to improvement, and transparency and improved payment is needed.

What we’re saying: As part of the panel, Premier reviewed its findings on >span class="MsoHyperlink">causes of drug shortages and suggested solutions to the problem. We think there are three main reasons for drug shortages: 1. There are both time and financial barriers to market entry for manufacturers. 2. The FDA needs more information insight and authority. 3. Problems in the supply chain can increase and perpetuate shortages. Read more in our drug policy roadmap.

WHY CAN’T WE BE FRIENDS

Yet another healthcare merger was approved last week, just after CVS closed its $70B deal with Aetna (awaiting final approval), and Walgreens and Humana said they want to be BFFs too.

What we’re saying: Consolidation activity across healthcare has largely been driven by the need for clinical integration to succeed in a value-based care delivery environment. These new partnerships are creating a much more dynamic and robust competitive environment in healthcare. Given the needs of consumers today, and the capabilities of the companies that are getting closer to the point of care, these moves aren’t just “nice to do.” They’re essential for the future. We’re working with several health systems that are taking steps to evolve in this way to better meet the needs of their consumers.

Source: www.premierinc.com